Presentation Decision Dilemmas in Adjunctive Pharmacology Choices in PCI Patients Presenter: Roxana Mehran April 15, 2013
News Daily News Danish Registry: Dabigatran Safe, Effective in Real-World Use Caitlin E. Cox April 05, 2013
News Daily News Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib March 28, 2013
Presentation Nuisance Bleeding with Prolonged Dual Antiplatelet Therapy After AMI and Its Impact on Health Status Presenter: A. P. Amin March 26, 2013
Presentation ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes Presenter: Gregg W. Stone March 26, 2013
News Conference News ACC 2013 Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months Jason Kahn March 11, 2013
News Conference News ACC 2013 STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital Yael L. Maxwell March 09, 2013
News Conference News ACC 2013 Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients L.A. McKeown March 09, 2013
News Daily News Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin Caitlin E. Cox March 09, 2013
News Conference News ACC 2013 PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device L.A. McKeown March 09, 2013
Presentation PCI Outcomes 2013 DAPT + Oral Anticoagulation: Indications and Risk Amelioration Presenter: C. Michael Gibson March 07, 2013
News Daily News AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab February 27, 2013
News Daily News ESC Position Paper Offers Guidance on Dual PPI and Antithrombotic Use Caitlin E. Cox February 27, 2013
News Daily News La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria February 25, 2013
News Daily News Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity February 25, 2013
News Daily News ACS Patients Benefit After Switching from Prasugrel to Clopidogrel but at a Cost Caitlin E. Cox February 24, 2013
Presentation TCT 2013 Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials. Presenter: Salvatore Cassese, Robert Byrne, Tomohisa Tada, Lamin King, Adnan Kastrati January 31, 2013
Presentation TCT 2013 Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability But Is Associated with Clinical Outcome After Percutaneous Coronary Intervention Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuck Kang, Jung-Kyu Han, Sang Eun Lee, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim January 31, 2013
Presentation TCT 2013 Can Amelioration of HDL-C Level by Pitavastatin Improve Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention? Presenter: Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Amro Elnagar, Sung Il Im, Sun Won Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong January 31, 2013
News Daily News La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent Jason Kahn January 22, 2013